Kamloops, Canada

Bruno Cinel

This inventor holds 1 USPTO granted patent. Top assignee: The University of British Columbia. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruno Cinel. Retrieved from https://idiyas.com/inventor/bruno-cinel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Bruno Cinel

Introduction

Bruno Cinel is a notable inventor based in Kamloops, Canada. He has made significant contributions to the field of chemistry, particularly in the development of antimitotic compounds. His work has implications for cancer research and treatment, showcasing the importance of innovation in scientific discovery.

Latest Patents

Bruno Cinel holds a patent for antimitotic terpenoid compounds, including sarcodictyin A and eleutherobin. These compounds can be obtained from organisms of the order Gorgonacea. The patent also includes methods for preparing such compounds, as well as novel antimitotic diterpene compounds characterized by a specific formula.

Career Highlights

Cinel is affiliated with the University of British Columbia, where he continues to engage in research and development. His work has led to advancements in the understanding of antimitotic compounds, which are crucial for developing new cancer therapies. With 1 patent to his name, he exemplifies the spirit of innovation in academia.

Collaborations

Throughout his career, Bruno Cinel has collaborated with esteemed colleagues such as Raymond John Andersen and Michel Roberge. These partnerships have enriched his research and contributed to the advancement of knowledge in his field.

Conclusion

Bruno Cinel's contributions to the field of antimitotic compounds highlight the vital role of inventors in scientific progress. His work not only advances academic research but also has the potential to impact cancer treatment significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…